Journal for ImmunoTherapy of Cancer (Nov 2020)

366 A randomized double-blind placebo-controlled phase III study evaluating perioperative toripalimab combined with platinum-based doublet chemotherapy in resectable stage III NSCLC

  • Jun Chen,
  • Wei Zhang,
  • Yu Zhang,
  • Tao Xu,
  • Ying Tian,
  • Ming Zhou,
  • Jie Jiang,
  • Minhua Ye,
  • Liwei Zhang,
  • Yunpeng Liu,
  • Wenxiang Wang,
  • Lin Wu,
  • Shun Lu,
  • Haohui Fang,
  • Guohua Yu,
  • Wenqun Xing,
  • Qixun Chen,
  • Xingya Li,
  • Nong Yang,
  • Wentao Fang,
  • Yunchao Huang,
  • Jichun Liu,
  • Lijie Tan,
  • Xiaosheng Hang,
  • Wengang Zhang,
  • Xun Zhang,
  • Aihong Zhong,
  • Shanqing Li,
  • Guowu Wu,
  • Xiaoyan Kang

DOI
https://doi.org/10.1136/jitc-2020-SITC2020.0366
Journal volume & issue
Vol. 8, no. Suppl 3

Abstract

Read online

No abstracts available.